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Summary.-The presence of Fc receptors on the surface of cell suspensions obtained
from a transplanted isogeneic methylcholanthrene induced murine fibrosarcoma
has been investigated by determining the capacity of such cells to form rosettes
with antibody coated SRBC.
These studies indicate that a large percentage of cells in the tumour had Fc
receptors on their surface. The proportion of such cells was increased by reducing
the number of cells transplanted, by administering cyclophosphamide to the host,
and on occasions by the i.p. injection of C. parvum. It was largely unaffected by the
route of tumour cell transplantation or by T cell depletion of the host before trans-
plantation but appeared to decline in older (i.e. larger) tumours. Both phagocytic
and non-phagocytic cells had Fc receptors on their surface. The phagocytic
population appeared to be affected most by procedures which altered the overall
percentage of Fc receptor bearing cells. The Fc receptor bearing tumour cells
were separated from those devoid of Fc receptors on the basis of their adherent
properties. Upon transplantation to isogeneic hosts both populations gave rise
to tumours containing a high percentage of Fc receptor bearing cells. These studies
suggest that many of the Fc receptor bearing cells in our tumour are probably
infiltrating cells of host origin. Their significance in relation to tumour growth
remains to be established.
DETAILED studies during the past few
years have convincingly demonstrated
that normal and malignant lymphoid and
reticuloendothelial cells may have on
their surface receptors for antigen/anti-
body complexes and aggregated JgG, the
so-called Fc receptors (reviewed by Kerbel
and Davies, 1974). A number of observa-
tions also indicate that a significant
proportion of the cells in certain non-
lymphoreticular tumours may also possess
Fc receptors (Milgrom et al., 1968; Cohen,
Gurner and Coombs, 1971; Tonder, Morse
and Humphrey, 1974; Kerbel and Davies,
1974). These Fc receptors have been
demonstrated by both cryostat haemad-
sorption techniques (Milgrom et al., 1968;
Tonder et al., 1974) and by conventional
rosetting procedures with suspensions of
tumour cells and antibody coated sheep
erythrocytes (Cohen et al., 1971; Kerbel
and Davies, 1974). The tumours studied
included a variety of human adenocar-
cinomata and epidermoid carcinomata
(Tonder et al., 1974), tumours of murine
connective and epithelial tissue (Kerbel
and Davies, 1974) and a transmissible
venereal tumour in the dog (Cohen et al.,
1971).
With the exception of the studies on
the transmissible venereal tumour, the
identity of the Fc receptor bearing cells
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in these noni-lymphoreticular tumours is
unknown. It remains to be established
if the Fe receptors are on tumour cells
or on infiltrating host cells which are
believed to be present in large numbers
in a variety of tumours (Evans, 1972).
However, as stressed by Kerbel and
Davies (1974), the presence within tu-
mours of cells with Fe receptors on their
surface is of considerable interest for
they could influence tumour growth in
a number of ways. For example, the
binding of complexes of tumour antigen
and antibody to Fc receptors on tumour
cell surfaces could impede the access
of aggressor cells. Alternatively, tumour
cells with Fc receptors could conceivably
destroy antibody coated tumour cells by
a mechanism similar to that which
operates in the antibody dependent cell
mediated cytotoxicity reaction (MacLen-
nan, 1972). Furthermore, if the major
proportion of Fc receptor bearing cells
in tumours is macrophages, then this
would provide an additional method for
monitoring the macrophage content of
tumours and establishing their importance
in relationship to tumour growth.
In view of these possibilities, we
have investigated the Fc receptor bearing
cell content of a transplanted syngeneic,
methyleholanthrene induced mouse fibro-
sarcoma. We have been particularly
interested in ascertaining what factors
influence the relative proportion of Fc
receptor bearing cells in this tumour.
The factors investigated include: (a) the
dose and route of injection of tumour
cells, (b) the effect of Corynebacterium
parvrun (C. parvum) and other related
organisms and (c) the effect of immuno-
suppressive procedures such as T cell
depletion and cyclophosphamide adminis-
tration. In addition, we have performed
investigations to establish whether Fc
receptor bearing cells are present in
tumours arising following the transplanta-
tion of tumour cell suspensions devoid
of Fe positive cells. Finally, we have also
assessed the phagocytic activity of the Fe
receptorbearingcellspresentinourtumour.
MATERIALS AND METHODS
Mice. The experiments were performed
in inbred CBA mice (both male and female)
aged 8-12 weeks. These mice were bred
by brother-sister mating from mice obtained
from the M.R.C. Laboratory Animals Centre,
Carshalton, Surrey.
Tumours.-The tumour used was an
isogeneic methylcholanthrene induced fibro-
sarcoma in its 18th transplant generation.
Details of the induction and propagation
of this tumour are recorded elsewhere
(Woodruff and Boak, 1966). Tumour cell
suspensions were prepared from freshly
excised tumours by teasing a tumour apart
in 5-10 ml of a pronase Dulbecco solution
and then incubating the suspension obtained
for 5-10 min at 37°C in the same solution.
The pronase Dulbecco solution contained
2-5 g of grade B pronase (Calbiochem Ltd,
London, England), 5 x 105 u penicillin, 5 mg
streptomycin and 0-2 mg neomycin in one
litre of Dulbecco balanced salt solution
(Oxoid, London, England) adjusted to pH
7-2. A short period of incubation was
adopted to avoid possible changes in the
tumour cell surface. The cell suspension
obtained was washed 3 times in Minimal
Essential Medium (MEM) (Gibco-Biocult
Glasgow, Scotland) and adjusted to 2 x 106
cells/ml before transplantation or use in
the rosette assay. Unless otherwise stated,
the cells were transplanted by subcutaneous
injection into the right thigh. The growth
of the tumour was assessed continuously
throughout each experiment by measuring
2 diameters at right angles. At the end
of the experiment the mice were killed by
ether inhalation or cervical dislocation.
Bacterial organi8ms.-The formalin killed
suspension of C. parvum strain no. CN6134
was a gift from the Wellcome Research
Laboratories, Beckenham, Kent. Formalin
killed suspensions of the other organisms
used, namely Propionibacterium freuden-
reichii strain no. 10470 and C. parvum
strain no. 10387, were kindly provided by
Dr W. H. McBride of the Department of
Bacteriology, University ofEdinburgh. They
had been prepared as previously described
from organisms obtained from the National
Collection of Type Cultures, Colindale, Eng-
land (McBride et al., 1975). Details of the
dose and route of injection of these suspen-
sions is contained in the Tables. For
practical reasons, smaller doses of C. parvumn
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were used when it was injected subcutaneous-
ly (see Table V) or immediately adjacent to
the site of a tumour (see Table VI). Unless
otherwise stated, strain CN6134 was used
throughout these studies.
Rosette technique.-The proportion of Fc
receptor bearing cells in tumour cell suspen-
sions was assessed by determining the
ability of such cells to form rosettes with
antibody coated sheep erythrocytes (SRBC).
The rosetting technique was undertaken as
follows:
Antiserum for coating the SRBC was
produced in CBA mice by injecting them
intraperitoneally (i.p.) with 4 x 108 washed
SRBC and bleeding them out 10 days later.
It was inactivated at 56°C for 30 min before
use in the rosette assays. Studies under-
taken with Sephadex G-200 fractions of
this serum indicated that the maximum
number of rosettes was obtained with SRBC
sensitized with the 7S fraction (see also
Milgrom et al., 1968). A series ofpreliminary
experiments was also performed to ascertain
the optimum conditions for the rosette form-
ing assay. On the basis of the results
obtained (see Fig. 1) the following procedure
was adopted:
Sensitized SRBC (EA-SRBC) were pre-
pared by incubating 1 ml of washed 5%
(vol/vol) SRBC with 1 ml of a 100-fold
dilution of mouse anti SRBC for 30 min
at 3700. The sensitized cells were then
washed 3 times and resuspended in 5 ml
ofthe MEM used throughout the sensitization
procedure.
The percentage of rosette forming cells
in a tumour was determined by mixing 0-25
ml of tumour cell suspension (containing
2 x 106 cells/ml) with 0-25 ml of 1%
EA-SRBC. This mixture was then centri-
fuged for 5 min at 2000 rev/min, after which
it was incubated at 370C for 30 min. Fol-
lowing incubation, the cells were carefully
resuspended using a Pasteur pipette and
the percentage of rosette forming cells
determined microscopically by counting at
least 200 tumour cells. In all cases the
rosette forming tumour cells were readily
discernible (see Fig. 2), cells with more than
10 adherent EA-SRBC being regarded as
positive.
The number of Fe receptor bearing cells
(that is, rosette forming cells) capable of
phagocytosing EA-SRBC was determined by
preparing a tumour cell EA-SRBC mixture
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FIG. 1-Factors influencing the sensitivity
of the rosetting technique used to detect
Fc receptors upon tumour cells.
The number of rosette forming cells
was determined after the mixture of
tumour cells and antibody coated SRBC
was subjected to the conditions indicated
in the figure. On the basis of these
results the SRBC were sensitized with
antibody diluted 100-fold and the rosettes
were routinely counted after centrifugation
and incubation at 370C for 30 min.
as above, adding 50,u1 of heat inactivated
foetal calf serum and incubating for 2 h
at 37°C in a shaking water bath. After
incubation, the cell mixture was gently
resuspended with a Pasteur pipette and
25-50 jul of the suspension was applied to
a microscope slide and covered with a glass
cover slip. Upon microscopic examination,
3 populations of cells could be readily dis-
tinguished, namely, (1) a population of
rosette forming cells which did not exhibit
phagocytosis (see Fig. 3); (2) rosette forming
cells showing clear erythrophagocytosis (see
Fig. 4), and (3) cells which did not bind
or phagocytose EA-SRBC (see Fig. 4). The
latter were designated Fc -ve cells. Pre-
liminary studies indicated that the phago-
cytic Fe receptor bearing cells could be
readily distinguished using SRBC sensitized
with a 100-fold dilution of anti-SRBC
antibody (see Fig. 5). This dilution was
therefore used in all subsequent tests.
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FIG. 2-The identification of Fc receptor bearing (rosette forming) cells in tumour cell suspensions.
A. Rosette formed between an Fc receptor bearing cells from a transplanted MC induced
fibrosarcoma and antibody coated SRBC. B. A non-receptor bearing cell from the same tumour.
C. Unbound antibody coated SRBC. Phase contrast. x 450.
Additional studies also revealed that the
number of cells phagocytosing antibody
coated SRBC was largely unaffected by
suspending the rosetting cells in tris buffered
NH4C1, thus confirming that the SRBC
were indeed phagocytosed and not simply
adherent to the tumour cell surface. Parallel
studies also indicated that the cells which
phagocytosed antibody coated SRBC also
took up colloidal carbon, thus confirming
their phagocytic properties. It should also
be stressed that the rosette formation
observed could be blocked by pretreating
the tumour cell suspension with heat aggre-
gated IgG. This treatment is used routinely
to block the formation of rosettes between
EA-SRBC and B cells or monocytes. In
order to compensate for possible variations
in the sensitivity and reproductivity of the
rosetting technique, untreated tumour bear-
ing control groups were included in every
experiment when effects of therapy were
being investigated. In addition, with one
unavoidable exception (see Table III) the
assays in all groups were always performed in
parallel.
Cell separation procedures.-Preparations
rich in Fe receptor bearing cells were isolated
from tumour cell suspensions by the following
procedure: Tumour cell suspensions prepared
as described earlier were resuspended at
a concentration of 2-3 x 106 cells/ml in
RPMI 1640 medium (Gibco-Biocult, Glasgow,
Scotland) containing 10% (vol/vol) heat
inactivated foetal calf serum, 2 mmol/l
glutamine, 100 u penicillin/ml and 100 ,ug
streptomycin/ml. Four ml of this suspen-
sion was poured into a 5 cm tissue culture
Petri dish (Product No 302V supplied by
Sterilin Ltd, Richmond, Surrey, England).
The dish was sealed with parafilm and
incubated for 2 h at 37°C. At the end of
this time the non-adherent cells were care-
fully removed by decantation and the
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FIG. 3. The identification of non-phagocytic Fc receptor bearing cells in tumour cell suspensions.
Note the multilayered nature of the rosette and the absence of any phagocytosis. The multi-
layered nature of the rosettes in this and subsequent figures is due either to (a) the cross-linking of
orythrocytes by free combining sites on some of the anti-SRBC antibody molecules used to coat
the SRBC or (b) the simple displacement ofloosely bound red cells from the surface of the tumour
cell as a result of applying the pressure of the cover slip. Oil immersion with bright field
illumination. x 915.
adherent cells gently washed 3 times with
RPMI-FCS, the washings being decanted on
each occasion. Finally the adherent cells
were dislodged from the dish by rubbing
with a rubber policeman. Practically all
of the adherent cells recovered formed
rosettes with EA-SRBC.
Tumour cell suspensions deficient in Fc
receptor bearing cells were obtained by 2
procedures. The first involved the further
processing of the non-adherent cell popula-
tion removed above. These cells were in-
cubated for a second and third time as
described in the preceding paragraph. The
non-adherent cell population obtained after
the third incubation was totally devoid
of Fc receptor bearing cells. The second
approach involved culturing tumour cell
suspensions in glass bottles for 10 days as
previously described by Ghaffar et al. (1974).
These cells were subcultured at least 4 times
before harvesting.
Presentation of result8.-The tumour di*-
meter values recorded are geometric mean
valuestogetherwiththelimitsofonestandard
error from the mean. The Fc receptor
bearing cells (both phagocytic and non-
phagocytic) and the Fc negative cells have
been calculated as a percentage of the total
number of cells in the original tumour cell
suspension and the values recorded are
arithmetic mean values j the s.e. mean.
The significance of the results has been
assessed using the Student t-test procedure,
values of P < 0 05 being regarded as sig-
nificant.
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FIG. 4. The iden.tification of phagocytic FC receptor bearing cells and i-on- receptor bearing cells
in tumour cell suspensions.
Note the phagocytic Fc receptor beariing cell (A) and the non-receptor hearinig cells (B). Oil
immersion. with bright field illtminatioin. x :365.
RESULTS
The effect of tumour cell dose, oute of
injection and time on the incidence of Fc
receptor bearing cells in a transplanted
synqeneicfibrosarcorna
The effect of cell dose was investigated
by injecting mice s.c. with between
1 x 103 and I x 106 viable tumour cells,
killing the mice 16 days later and then
determining both the phagocytic and
non-phagocytic Fc receptor bearing cell
content of individual tumour cell suspen-
sions. The results of this experiment are
summarized in Table I.
It will be observed that the total
Fe receptor bearing cell content was
inversely proportional to the size of the
initial tumour inoctultum. Fturthermore,
the higher incidence of Fc receptor
bearing cells in mice challenged with the
lower tumour doses was due almost
entirely to an increase in the phagocytic
component.
The influence of the route of trans-
plantation of tumour cells on the Fc
receptor cell content of the resultant
tumour was assessed by challenging mice
with I x 106 viable tumour cells by the
i.d., s.c., i.m. or i.p. routes and determining
the Fc receptor bearing cell content of
the excised tumour 14 days later. From
the results summarized in Table II it is
apparent that both the phagocytic and
non-phagocytic Fc receptor bearing cell
contents of tumours are not greatly
influenced by the route of tumour cell
transplantation.S. SZYMANIEC AND K. JAMES
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FIG. 5. The detection of phagocytic ai
non- phagocytic cells in tumour cell su
pensions using SRBC sensitized with
range of dilutions of antibody.
On the basis of the results shown t
phagocytic and non-phagocytic Fc x
ceptor bearing cell content of tumo
cell suspensions were routinely investigat
using SRBC sensitized with a 100-fo
dilution of antibody.
An examination of the total Fc
receptor bearing cell content of tumours
removed at different times following
transplantation indicated that as time
progressed, and the tumour increased in
size, so the percentage of Fc receptor
bearing cells decreased (see Table III).
The influence of bacterial organisms on the
Fc receptor bearing cell content of tumours
In view of the observations that C.
parvum and other bacterial organisms
readily inhibit the growth of the MC
1/1600 fibrosarcoma used in these studies (Mc-
Bride et al., 1975), a number of experi-
ments were performed to ascertain if
administration of these organisms in-
fluenced the Fc receptor bearing cell
content of tumours. While initially we
ad hoped that studies along these lines
.1d- might throw further light on the mechan-
a ism whereby adjuvants inhibit tumour
he growth, the somewhat inconsistent effects
re- ofC. parvum (see Tables IV-VII) confused
our rather than clarified the situation.
ed In our initial studies mice were chal- id lenged with 1 x 105 or 1 x 106 tumour
TABLE I.-The Effect ofthe Dose ofTumour Cells Injected on the Incidence ofFc Receptor
Bearing Cells in a Transplanted Syngeneic MC Fibrosarcoma*
% Tumour cellst
t I
Group
A
Nos. of tumour
Nos. of cells injected
mice s.c.
4 1x103
B 8 1x104
C 8 1x 105
D 8 1 x 106
Tumour
diameter
(mm)t
7+2
(6-4-8- 1)
10-6
(96-11. 7)
15-6
(14-8-16-5)
19*6
(18-9-20*3)
With Fc
receptors but
non-phagocytic
19-4±2* 6
23*0±3 2
25*5±3-6
17-3+4 1
With Fc
receptors and
phagocytic
44-3±4- 7
Without Fc
receptors
36-3±3-9
32*5±1.9§ 43 9±3 3
31-2±3-9§ 41*4±4*6
20*2±1-8§ 63 8±4 711
* All measurements made 16 days after tumour transplantation.
t Geometric mean with the limits of one standard error from the mean.
: Arithmetic mean ± s.e.
§ Significantly lower than in Group A (P 0-02-0* 001).
II Significantly greater than in Group A (P < 0
- 005).
Note.-The phagocytic Fc receptor bearing cell content of the tumour is inversely proportional to the
dose of tumour cells initially transplanted while the percentage of cells without Fc receptors is directly
proportional.
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TABLE II.-The Effect of the Route of Injection of Tumour Cells on the Incidence of Fc
Receptor Bearing Cells in a Transplanted Syngeneic MC Fibrosarcoma*
% Tumour cellst
-
K
A
Nos. of 1 x 106 tumour
Group mice cells injected
A 6 Intradermally
(i.d.)
B 6 Subcutaneously
(s.c.)
C 6 Intramuscularly
(i.m.)
D 3 Intraperitoneally
(i.p.)
Tumour
diametert
(mm)
9 3
(9-2-9-5)
11-7
(11- 1-12-4)
12-8
(12-2-13-5)
With Fc
receptors but
non-phagocytic
24- 7+11- 6
27-0+3-
With Fc
receptors and Without Fc
phagocytic receptors
35-7±2-9 39-2±5-2
36-2±1-8 40-6+4-3
20-6±6-3 43-8±5-4 35-6±5-9
28-3+5-0 29-3±2-7 42-3±3-4
* All measurements made 14 days after tumour transplantation.
t Geometric mean with the limits of one standard error from the mean.
t Arithmetic mean ± s.e.
Note. The route of transplantation of the tumour cell inoculum has a negligible effect on the receptor bearing cell content of the resultant tumour.
TABLE III.-The Effect of Time on the Incidence of Fc Receptor Bearing Cells in a
Transplanted Syngeneic Fibrosarcoma*
Nos. of
Group mice Day examined
A 5 12
B 5 14
C 7 18
Tumour diameter
(mm)t
14- 1 (13 -8-14-4)
16-8 (16-2-17-4)
22-2 (21- 9-22-5)
% Cells with Fc
receptors$
40-4±8-2
32*8±6-8
16-7±3-2§
* 1 x 106 tumour cells injected s.c. on Day 0.
t Geometric mean with the limits of one standard error from the mean.
$ Arithmetic mean + s.e.
§ Significantly lower than in Group A or Group B (P 0-005-<0-001).
Note.-The total Fc receptor bearing cell content of the tumour declines as its age (and size) increases.
TABLE IV.-The Effect of C. parvum on the Incidence ofFc Receptor Bearing Cells in a
Transplanted Syngeneic MC Fibrosarcoma
Nos. of
tumour cells
Group transplanted
A lx105
B 1x 105
C IX106
D 1 x 106
C. parvum
administered
(1-4mg i.p.)
No
Yes
No
Yes
Tumour diameter
(mm)*
Day 12 or 13 Day 28 or 29
8-4 9-7:
(7 7-9.3) (9-5-10-0)
6-0 7-2
(5 6-6.4) (6-4-8-1)
10-7
(9 6-11. 9)
8-9
(8 2-7 8)
16-0
(12.6-20 5)
14-0
(12.0-16-4)
% Cells with Fc receptorst
Day 12 or 13 Day 28 or 29
46-0±10.4 36-510-7$
56-0±8-3 67-3±28-3§
49-3±7-1 31-5±10.3
48-0±6-6 45;8±11.8§
* Geometric mean together with the limits of one standard error from the mean.
t Arithmetic mean ± s.e.
t Only 2 mice examined. On all other occasions a minimum of 3 examined.
§ Significantly greater than in non-C. parvum treated controls.
Note.-The administration of C. parvum appears to halt the decline in the relative proportion of Fc receptor bearing tumour cells.
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TABLE V.-The Effect of the Route of Administration of C. parvum on the Incidence
ofFc Receptor Bearing Cells in a Transplanted Syngeneic MC Fibrosarcoma*
Nos. of Tumour diameter % cells with Fc
Group mice Treatment (mm)t receptorst
A 10 None 11-2(9-8-12-8) 45-1±8-4
B 10 C. parvum 10-6 (9-8-11-4) 41-0±6-6
(0 7 mg s.c. Day 3)
C 7 C. parvum 8-0(7.2-8.9) 43-9±4*3
(0 7 mg i.p. Day 3)
* All animals injected s.c. with1 x 105 tumour cells on Day 0 and assays performed 23 days later.
t Geometric mean together with the limits of one standard error from the mean.
t Arithmetic mean ± s.e.
Note. On this occasion the administration of C. parvum had no effect on the overall proportion of Fc
receptor bearing cells.
TABLE VI.-The Effect on the Incidence of Fc Receptor Bearing Cells in a Transplanted
Syngeneic MC Fibrosarcoma of C. parvum Administered Adjacent to the Tumour Site
% Tumour cellst
With Fc With Fc
Nos. Tumour receptors receptors Without
of Day diameter but non- and Fc
Group mice examined Treatment* (mm)t phagocytic phagocytic receptors
A 11 16 Nil 18-8 15*9±1*8 26-64±21 57-5±2 5
(18- 4-19- 3)
B 6 16 07mgC.parvum§injected 18-9 23.4±2.511 31-0±2.0 45 7±6 811
adjacent to tumour on (18-2-19-6)
Day 8
C 4 21 Nil 24-1 36-5±7*7 25-2±5-9 38-3±5-3
(23.8-24.4)
D 4 21 0 7 mgCparvuminjected 21-9 28-8±3*6 30-8±6-0 40 5±7*9
adjacent to tumour on (21.0-22.8)
Day 8
* All mice injected s.c. with 1 x 106 tumour cells on Day 0.
t Geometric mean with the limits of one standard error from the mean.
t Arithmetic mean ± s.e.
§ At the time of C. parvum injection tumour diameter was 9 mm and the total Fc receptor bearing cell
content of tumour excised at this time was 64%.
11 Significantly different from control group A (P 0 01-0- 025).
Note.-In general, the administration of C. parvum close to the site of a growing tumour had little
effect on the Fc receptor bearing cell content of the tumour.
TABLE VII.-The Effect of Various Bacterial Organisms on the Incidence ofFc Receptor
Bearing Cells in a Transplanted Syngeneic MC Fibrosarcoma
Nos. of Tumour diameter % Cells with
Group mice Organism injected* (mm)t Fc receptorst
A 8 None 16-3 39*7±7 1
(15-5-17-2)
B 8 C. parvum strain No. CN6134 9.2§ 56-3±10-0§
(7-9-10-3)
C 8 Propionibacterium freudenreichii 14-6 35-8±10-3
strain No. 10470 (13-3-16*1)
D 8 C. parvum strain No. 10387 9.0§ 58-4±8-6§
(8- 1-9-9)
* The organisms were injected i.p. 3 days after the transplantation of 1 x 105 tumour cells. In Groups
B and C 1-4 mg dry weight of organism was injected, while in Group D, 0-7 mg.
t Geometric mean together with the limits of one standard error from the mean.
tArithmetic mean ± s.e.
§ Significantly different from untreated controls (P 0-005-<0 001).
Note.-On this occasion the preparations which inhibit tumour growth also result in a marked increase
in the Fc receptor bearing cell content of the tumour.
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cells and injected i.p. 3 days later with
1-4 mg of C. parvum. Control mice re-
ceived tumour alone. These studies sug-
gested (see Table IV) that the C. parvum
protocol used did not exert a dramatic
effect upon the Fc receptor bearing cell
content of transplanted tumours, at least
in their early stages of growth. It did
appear, however, to halt the dramatic
decline in the Fc positive cell content
noted in older tumours, though further
experiments with larger numbers of ani-
mals will be necessary to establish this
point.
An experiment was also performed
to see if the effect, if any, of C. parvum
on the Fc receptor bearing cell content
of tumours was dependent upon the
route of administration of C. parvum,
as this is known to influence the anti-
tumour effect of this reagent (Woodruff,
McBride and Dunbar, 1974; Scott, 1974).
In these experiments mice were challenged
with tumour cells on Day 0 and injected
s.c. or i.p. with 0 7 mg of C. parvum
3 days later. The animals were killed
23 days after tumour cell transplantation
and the total Fc receptor bearing cell
content of the tumours determined. It
was found that the administration of C.
parvum by either the s.c. or the i.p.
route failed to influence the total Fc
receptor bearing cell content of the
tumours (see Table V). It should also
be noted that, as previously observed,
the i.p. administration of C. parvum
significantly inhibited tumour growth
while s.c. administration at a site distant
from the tumour was without effect
(Woodruff et al., 1974; Scott, 1974).
The effect oflocal administration of C.
parvum was determined by injecting 0 7
mg dry weight of this organism s.c.
immediately adjacent to the site of a
growing tumour. The C. parvum was
injected 8 days after the transplantation
s.c. of 1 x 106 viable tumour cells.
Previous studies in our laboratory had
shown that this C. parvum protocol in-
hibited the growth of tumour arising
following the s.c. transplantation of 1 x 104
4
tumour cells (WoodruffandDunbar, 1975).
However, it will be observed that in the
present experiment (see Table VI) it had
little effect on tumour growth or on the
Fc receptor bearing cell content of the
tumour. Thus, it appears that the ef-
fectiveness of this protocol may be
dependent on the number of tumour cells
initially transplanted.
The most dramatic effect of C. parvum
therapy on the total Fc positive cell
content of tumours was obtained in
experiments set up to compare the effects
of 3 different preparations of formalin
killed bacteria. In these experiments
mice were challenged with 1 x 105 syn-
geneic tumour cells on Day 0 and 3 days
later were injected i.p. with the prepara-
tions listed in Table VII. The percentage
of Fc receptor bearing cells in individual
tumour cell suspensions was determined
24 days after tumour transplantation.
The 2 strains of C. parvum tested signifi-
cantly inhibited tumour growth and also
significantly increased the proportion of
Fc receptor bearing cells in the excised
tumour. In contrast, the administration
of P. freundenreichii failed to inhibit
tumour growth or to alter the incidence
of Fc receptor bearing cells (see Table
VII). It should be noted that the effects
of P. freundenreichii and C. parvum
strain 10387 on tumour growth are some-
what different than previously reported
(McBride et al., 1975). This might, how-
ever, be due to differences in the number
of tumour cells transplanted and the
weight of organisms injected.
The incidence of Fc receptor bearing cells
in immunologically deprived and immuno-
suppressed mice
Previous reports from our laboratory
have shown that i.p. administered C.
parvum exerts an anti-tumour effect in
T cell deprived, that is, B mice (Woodruff,
Dunbar and Ghaffar, 1973). In an at-
tempt to further elucidate the mechanism
by which C. parvum exerts an anti-
tumour effect in B mice the following
experiment was performed:
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Mice were thymectomized at the age
of 4-6 weeks and one week later they
received 850 rad whole body irradiation,
followed 8 h later by the i.v. infusion
of 4 x 106 anti-O antibody treated iso-
geneic bone marrow cells. Six weeks
after reconstitution the mice were chal-
lenged with 1 x 104 tumour cells and
after a further interval of 3 days 1*4 mg
of C. parvum was injected i.p. Control
mice were sham thymectomized, irradiated
and reconstituted as above.
The incidence of Fc positive tumour
cells was no different in thymectomized
mice than in sham thymectomized controls
(see Groups A and C, Table VIII).
Furthermore, the percentage of such cells
was not significantly affected by the
administration of C. parvum even though
it significantly inhibited the growth of
tumour in the B mice. It will be noted,
however, that the proportion of Fc
positive cells in all groups was greater
than normally observed. Whether or
not this is a property of tumours grown
in irradiated bone marrow reconstituted
mice, or a reflection of the variability
of the rosetting procedure, remains to be
established.
The effect ofimmunosuppressive treat-
ment on the Fc receptor bearing cell
content of tumours was investigated by
treating tumour challenged mice with
cyclophosphamide as indicated in Table
IX. This treatment was found to signifi-
cantly inhibit the growth of transplanted
tumour and at the same time significantly
increase its proportion of phagocytic Fe
receptor bearing cells. The proportion
of non-phagocytic Fc positive cells was
not significantly affected by cyclophos-
phamide administration.
Fc receptor bearing cells in tumours grown
from Fc deficient and Fc enriched tumour
cell suspensions
In these experiments mice were chal-
lenged s.c. with tumour cell suspensions
deficient or enriched in Fe receptor
bearing cells. These suspensions were
prepared as described earlier. Both types
of preparation gave rise to tumours in
which there were cells expressing Fc
receptors on their surface (see Table X).
The Fc receptor bearing cells were found
in all the tumours grown from Fc negative
tumour cell suspensions and were present
in high numbers within 7 days of tumour
cell transplantation.
DISCUSSION
These studies demonstrate convinc-
ingly that a significant proportion of the
TABLE VIII.-The Incidence ofFc Receptor Bearing Tumour Cells in B Mice and
the Effect of C. parvum Therapy Thereupon
Nos. of
Group mice Treatment
A 4 Sham thymectomized mice, x-irradiated, repopulated
with anti-0 treated bone marrow cells and chal-
lenged (s.c.) with 1 x 104 tumour cells
B 4 As in A but also injected (i.p.) with 1 4 mg C. parvum
3 days after tumour transplantation
C 7 Thymectomized mice, x-irradiated, repopulated with
anti-0 treated bone marrow cells and challenged
(s.c.) with 1 x 104 tumour cells
D 8 As in C but also injected (i.p.) with 1*4 mg C. parvum
3 days after tumour transplantation
Tumour
diameter
(mm)*
12-1
(10.5-14-0)
82
(7-1-9.5)
14-4
(13-7-15*2)
11-2T
(10.7-11*9)
% Cells with
Fc receptorst
84-8±8-3
62 3±14 1
75-6±2-2
79 0±5 4
* Geometric mean together with the limits of one standard error from the mean.
t Arithmetic mean ± s.e.
t Significantly lower than in Group C (P 0 005).
Note the high incidence of Fc receptor bearing cells in tumours grown in B mice. In addition, this is
unaffected by C. parvum administration.
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TABLE IX.-The Effect of Cyclophosphamide on the Incidence of Fc Receptor Bearing
Cells in a Transplanted Syngeneic MC Fibrosarcoma*
Treatment
1 x 106 tumour cells (s.c.) on Day 0
Tumour
diameter
(mm)t
18-8
(18.4-19.3)
% Tumour cells4
r A
A
With Fc With Fc
receptors receptors Without
but non- and Fe
phagocytic phagocytic receptors
15-9±1-8 26-6±2-1 57-5±2-3
B 8 1 x 106 tumour cells (s.c.) on Day 0 and 9 7 21-6±2-7 43-8±2-3§ 34-6±3.411
cyclophosphamide (200 mg/kg i.p.) (9- 0-10.5)
on Days -5 and 8
C 8 1 x 108 tumour cells (s.c.) on Day 0 and 10*5 12-3±2-8 41.0±3*9§ 46-8±5-O1l
cyclophosphamide (200 mg/kg i.p.) (9- 5-11 6)
on Day 8
* All assays performed 16 days after tumour transplantation.
t Geometric mean values together with the limits of one standard error from the mean.
I Arithmetic mean s.e.
§ Significantly higher than in non-cyclophosphamide treated controls (P 0§005-<0-001).
11 Significantly lower than in non-cyclophosphamide treated controls (P 0-005-<0-001).
Note the increased percentage ofphagocytic Fc receptor bearing cells in tumours from cyclophosphamide
treated mice.
TABLE X.-The Incidence ofFc Receptor Bearing Cells in Tumours Grownfrom Pc Defi-
cient and Fc Enriched Tumour Cell Suspensions
Tumour cells transplanted*
Group Source
A Cultured tumour
cells
B Non-adherent cells
from freshly ex-
cised tumour
C Adherent cells
from freshly ex-
cised tumour
% with Characteristics
Fc re- of resultant
ceptors tumourt 7
0 % cells with Fc
receptors
Tumour diameter
(mm)
0 % cells with Fc 65 36,58,
receptors
Tumour diameter 6-5 12,11,
(mm)
99.9 % cells with Fc 75 85,98
receptors
Tumour diameter 3 5,8
(mm)
Day measured
L3 16 18 28
58 45,52,57,60 38
7.5 9,13,8-5 22
,57,75 36
,10,5 12
60
6
51,99
19,20
* 1 x 105 cells transplanted s.c.
t The values expressed are for individual mice.
Note.-Tumour cell suspensions devoid of Fc receptor bearing cells gave rise to tumours containing a
high proportion of Fc receptor bearing cells.
cells in our transplanted MC induced
fibrosarcoma have Fe receptors on their
surface for they readily form rosettes
with antibody coated SRBC, thus con-
firming the results noted with a variety
of other tumours (Milgrom et al., 1968;
Cohen et al., 1971; T0nder et al., 1974;
Kerbel and Davies, 1974). They also
extend previous observations by throwing
further light on the nature of the Fe
receptor bearing cells and factors which
influence their incidence in tumours.
They fail, however, to establish their
relationship, if any, to tumour growth.
A number of observations lead us to
believe that many (though not all) of
the Fc receptor bearing cells in our
tumour are probably infiltrating macro-
Nos.
of
Group mice
A 11
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phages of host origin. Such a possibility
hacd previously been suggested by Kerbel
and ]Davies (1974) on the basis of the
observations that certain tumours contain
large numbers of infiltrating macrophages
(Evans, 1972), and these cells are known
to possess Fc receptors on their surface
(Lay and Nussensweig, 1968). The Fc
receptor bearing cells in our tumour
adhere to plastic and glass and many
of them exhibit phagocytosis of antibody
coated SRBoC. In addition, other ob-
servations indicate that a large proportion
of these cells phagocytose colloidal carbon
(L. Gruer, unpublished) and preliminary
studies suggest that they can be separated
by a magnet following ingestion of
carbonyl iron. The rapid appearance of
Fe receptor bearing cells in tumours
grown from Fc negative tumour cell
suspensions leads one to conclude that
the Fc positive cells are most probably
infiltrating cells of host origin, a con-
clusion also reached by Evans (1972)
with respect to host macrophages. How-
ever, before the host origin of these cells
can be established beyond all reasonable
(loubt, further studies will be necessary
with tumours transplanted in F1 hybrid
mnice or CBA T6 mice. Such studies
would permit recognition of host cells
by their cell surface antiuens or chromo-
some markers.
Although all Fe receptor bearing cells
can be removed by incubation in plastic
Petri dishes, or by subculture of cell
lines in glass bottles, a significant pro-
portion of these cells do not phagocytose
antibody coated SRBC or colloidal carbon.
Whether or not these non-phagocytic
cells are " inactive macrophages ", genuine
tumour cells or other lymphoreticular
cells still remains to be established.
While the observation (see Table X) that
tumours grown from cell preparations
consisting almost entirely of Fc receptor
bearing cells could be taken to indicate
that tumour cells as such may express
Fc receptors on their surface, the possi-
bility still remains that the tumours
arose from small numbers of Fc negative
tumour cells present within the inoculum.
The transplantation of a range of doses
of the Fc enriched suspension should
help resolve this matter. Other studies
currently under way in our laboratory
indicate that our tumour cell suspensions
also lyse antibody coated erythrocytes
in culture, that is, exert K cell cytolysis
(Ghaffar et al., 1975). Experiments are
in progress to characterize the effector
cell in this system and to establish if it is
of host origin.
The present studies demonstrate that
a number of factors influence the relative
proportion of Fc receptor bearing cells
in our tumour. For example, it may be
increased by transplanting small doses
of tumour cells (contrast Evans, 1972), by
the administration of cyclophosphamide
and on occasion by the i.p. injection of
certain adjuvants. In all these cases
it is interesting to note that the pro-
cedures used limit the size of the tumour.
Conversely, if large tumour doses are
transplanted, or the tumour is allowed
to grow for a longer time, then the
proportion of Fc receptor bearing cells
decreases. This is undoubtedly due to a
disproportionate increase in the Fc nega-
tive population and not to an actual
decline in the absolute numbers of Fc
receptor bearing cells. These observa-
tions suggest that procedures which limit
tumour growth are those which favour a
high Fc +ve/Fc -ve (and presumably
macrophage/tumour) cell ratio. If this
is so, then one has to explain the some-
what inconsistent effects of C. parvum
for occasionally it exerted an appreciable
antitumour effect without increasing the
proportion of Fc receptor bearing cells
(see Table V). In addition, Eccles and
Alexander (1974) have shown that BCG
can exert an anti-tumour effect without
significantly increasing the macrophage
content of tumours. Nevertheless, it is
conceivable that the C. parrurn protocol
used in Table V increased the proportion
of phagocytic Fc receptor bearing cells
and that this population influences tumour
growth.
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The observation that tumours grown
in B mice also have as many Fc receptors
on their cell surfaces as appropriate
control mice is of interest. As expected,
it confirms that these adherent Fc receptor
bearing cells are not of T origin or de-
pendent upon T cells for their generation.
Furthermore, it also suggests that their
localization within tumours is not a
consequence of the release of soluble
factors (lymphokines) following contact
of tumour antigen and T cells. In con-
trast to our observations others have re-
ported that prior thymectomy and x-irra-
diation of rats influences the macrophage
content of a transplanted syngeneic benz-
pyrene induced fibrosarcoma, the level
being much lower than in sham thymec-
tomized controls (Eccles and Alexander,
1974). However, in these experiments
the thymectomized x-irradiated rats were
not repopulated with bone marrow cells
as in our studies, and this may have
contributed to the difference.
Although these results establish clearly
that many of the cells in tumour cell
suspensions bear Fc receptors upon their
surface and indicate that a large pro-
portion of such cells are phagocytic, the
precise significance of these cells in rela-
tion to tumour growth remains to be
established. Further studies on the pro-
portion of phagocytic and non-phagocytic
rosette forming cells in tumours and the
effect of various therapeutic procedures
thereupon will undoubtedly help elucidate
their importance in tumour surveillance.
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Addendum.-Since submitting this paper
for publication we have noted a recent
article by Kerbel, Pross and Elliot (Int. J.
Cancer, 1975, 15, 918) recording results
similar to our own. These authors demon-
strate convincingly that a variety oftumours
contain Fc receptor bearing cells, the
majority of which are phagocytic. These
cells were also lost following culture in
vitro and transplantation of the cultured
cells also gave rise to tumours containing a
high proportion of Fc receptor bearing
cells. Cytotoxic studies with anti-H2 sera
on tumours transplanted to F1 hybrids
indicated that many (if not all) of the Fc
receptor bearing cells were of host origin.
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